The company’s strong financials and innovative collaborations, such as its partnership with AdvanCell to develop targeted cancer therapies, further enhance its appeal.

Eli Lilly and Company (NYSE:LLY) tops our list for being one of the best pharmaceutical stocks. It develops, manufactures, discovers, and sells pharmaceutical products. These goods cover ...

Cancer treatment start-up AdvanCell’s raised $171 million and Aravax raised $66 million to help grow its allergy symptom reduction products. The average deal size rose to an all-time high over ...

While biotech and medtech startups dominated total capital raised — buoyed by a $179 million raise by Harrison.ai and a $178.6 million round for cancer treatment startup AdvanCell — AI edged ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The research program is enabled by AdvanCell’s proprietary (Lead-212) 212 Pb alpha isotope production technology along with the delivery of a first-in-field clinical platform trial to accelerate ...

A Nuclear Regulatory Commission advisory committee recently discussed how NRC can better navigate the growing market for the medical use of isotopes. At NRC’s April 8 meeting, nuclear pharmacist ...

The company also represents Advancell expandable microspheres and S-LEC BK polyvinyl acetal resins. Sekisui Specialty Chemicals is a subsidiary of the Sekisui Chemical Group, a multibillion dollar, ...

Eli Lilly and Company (NYSE:LLY) develops, manufactures, discovers, and sells pharmaceutical products. These products span oncology, diabetes, immunology ...

The company also represents Advancell expandable microspheres and S-LEC BK polyvinyl acetal resins. Sekisui Specialty Chemicals is a subsidiary of the Sekisui Chemical Group, a multibillion dollar ...